Cysteine (Base) Powder

L-Cysteine Base Powder is a fermentation-derived, carrier-free sulfur amino acid supplied in its free-base form. Identified by CAS 52-90-4, this crystalline ingredient is suitable for evaluating supplement formulations, amino acid premixes and selected food-processing applications. Bulk supply includes agreed product specifications, batch documentation and protective packaging for professional formulation, purchasing and quality-control teams.

Top Key Specs

SpecificationProduct Information
Product nameL-Cysteine Base Powder
Chemical name and synonymsL-Cysteine; L-cysteine free base; cysteine free base powder
CAS number52-90-4
Molecular formula and weightC₃H₇NO₂S; approximately 121.16 g/mol
Chemical formFree amino acid without a hydrochloride counterion
SourceFermentation-derived
Manufacturing processFermentation, purification, crystallization, drying, sieving and batch release testing
GradeFood or supplement grade, subject to intended application and destination-market requirements
Appearance and odorWhite crystals or white crystalline powder with a characteristic mild sulfur note
AssayConfirmed against the approved specification; typically reported on a dried basis
CarrierCarrier-free standard supply
Particle sizeStandard or project-specific mesh
MoistureControlled through the agreed loss-on-drying specification
Additional physical parametersWater activity, bulk density and flow characteristics available when required
pHEvaluated at the agreed solution concentration
SolubilitySoluble in water; finished-formula performance requires practical evaluation
Standard packagingTypically 25 kg with protective inner packaging
Shelf lifeTypically 24 months unopened under suitable storage conditions
DocumentationCOA, TDS, SDS and supported project-specific declarations
Origin and suitability statementsProvided only when supported by applicable product and supply documentation

The free-base form differs from L-Cysteine Hydrochloride Anhydrous Powder and L-Cysteine Hydrochloride Monohydrate Powder in chemical composition, molecular weight and formulation requirements. The absence of a hydrochloride counterion does not guarantee the absence of residual chloride.

Typical COA Limits

Final test items, numerical limits, analytical methods and reporting requirements are confirmed in the approved product specification.

Test ItemSpecification / Reporting
AppearanceWhite crystals or white crystalline powder
IdentificationIR, chemical identification or another agreed method
AssayReported on the approved basis, typically dried basis
Specific optical rotationIncluded when required for identity or stereochemical assessment
Loss on dryingControlled against the agreed moisture specification
pHDetermined at the agreed solution concentration
Residue on ignitionEvaluated against the approved inorganic-residue requirement
Particle sizeConfirmed when a specific mesh or particle-size distribution is required
L-cystineOxidation-related impurity monitored when specified
Related substancesEvaluated according to the agreed impurity profile
Chloride, sulfate and ammoniumControlled according to application-specific requirements
Heavy metalsApplicable controls for lead, arsenic, cadmium and mercury
Total aerobic microbial countEvaluated against the approved microbiological specification
Yeast, mold and specified pathogensIncludes applicable controls for yeast, mold, Escherichia coli and Salmonella
Additional project-specific testsWater activity, bulk density, solution appearance or relevant residual solvents

A useful batch COA should identify the ingredient, lot number, analytical methods, acceptance criteria and actual test results. The assay reporting basis deserves particular attention because a dried-basis value does not automatically represent the ingredient concentration in its supplied condition. Buyers should also review identity testing, specific optical rotation, moisture, particle size and application-specific impurity controls. Because L-cysteine may oxidize to cystine, it is important to distinguish the free-base ingredient from L-Cystine Powder and determine whether oxidation-related monitoring is required. Residual chloride may also remain relevant even though this ingredient is not supplied as a hydrochloride salt. Heavy-metal and microbiological requirements should reflect the approved specification and intended market. Additional measurements, including bulk density, water activity and solution appearance, can support specific formulation or processing needs. Essencefield coordinates testing and certification support, including applicable batch documentation and additional verification when requested. Commercial release should proceed only after the agreed test scope, documentation and acceptance criteria have been confirmed.

Features & Benefits

  • Free-base chemical form: Supplies L-cysteine without a hydrochloride counterion.
  • Fermentation-derived sourcing: Supports documented raw material and supply-chain review.
  • Carrier-free composition: Standard supply does not include added carriers.
  • Formulation versatility: Suitable for evaluating supplements, amino acid premixes and selected food-processing systems.
  • B2B quality support: Assay basis, impurities, particle size and batch documentation can be reviewed against project requirements.

Applications & Formulation Ideas

ApplicationMain Consideration
Capsules and tabletsFilling behavior, particle size and blend uniformity
Amino acid premixesAssay reporting basis and consistent ingredient distribution
Powder blends and sachetsFlowability, humidity control and protective packaging
Beverage powdersDissolution, pH, sulfur notes and formulation stability
Selected food-processing systemsIngredient grade, processing conditions and destination-market suitability
Mineral-containing formulationsOxidation risk and compatibility with iron, copper or other ingredients

Formulation guidance:

  • Verify that the ingredient is L-cysteine free base rather than a hydrochloride salt, cystine or N-acetylcysteine.
  • Confirm the assay reporting basis before calculating the formulation addition rate.
  • Assess compatibility with glycine in amino acid premixes.
  • Assess compatibility with glutamic acid in selected amino acid or food-processing systems.
  • Preblend with a suitable portion of the formula to improve ingredient distribution.
  • Minimize unnecessary oxygen exposure during processing and storage.
  • Control ambient humidity and reseal opened packaging promptly.
  • Evaluate potential interactions with iron, copper and other formulation components.
  • Validate dissolution, pH, sulfur notes and stability under actual processing conditions.
  • Release production batches against the approved specification and applicable COA.

Application performance depends on the ingredient’s chemical identity, assay basis and complete formulation environment. In capsules and tablets, particle size, bulk density and blend uniformity influence filling and manufacturing consistency. Amino acid premixes benefit from appropriate preblending and accurate ingredient calculations based on the approved assay. Powder blends and sachets require attention to flowability, humidity exposure and packaging protection. Beverage powders should be evaluated for dissolution, solution pH, sulfur notes and stability under representative processing conditions. Selected food-processing applications must be assessed against the ingredient grade, intended use and destination-market requirements. Formulations containing iron or copper deserve additional compatibility review because certain mineral systems can increase oxidation risk. Moisture-rich systems may also require further stability and sensory assessment before commercial production. Formulators should conduct representative product trials, establish application-specific acceptance criteria and select packaging appropriate for the identified moisture and oxygen risks. Final production release should be supported by the approved product specification, corresponding batch documentation and documented quality review.

Packaging, Storage & Logistics

ItemSupply Information
Bulk packagingTypically 25 kg fiber drums, cartons or another agreed bulk format
Inner packagingDouble PE liners or other suitable moisture-protective packaging
StorageKeep sealed in a cool, dry location protected from moisture, oxygen, excessive heat and direct sunlight.
Shelf lifeTypically 24 months unopened under suitable storage conditions
TransportCourier, air freight or sea freight according to shipment requirements
Shipping documentsCommercial invoice, packing list, COA, SDS and other applicable documentation

Reseal opened packaging promptly and maintain batch identification throughout storage, handling and production.

MOQ, Lead Time, Documents & Inquiry

Minimum order quantity: Typically 25 kg, subject to availability and project requirements.

Samples: Typically available in 100 g, 500 g or 1 kg quantities.

Lead time: Confirmed according to inventory, order volume, packaging, testing and documentation requirements.

Documents: Batch-specific COA, TDS, SDS and product specification. Origin, allergen, GMO, gluten, vegan and certification-related statements are provided only when supported by applicable documentation.

To request a quotation, please provide:

  • Required order quantity.
  • Intended application.
  • Destination market.
  • Required specification, testing or documentation.
  • Preferred packaging and delivery requirements.

For additional information about chemical identity, solubility and quality assessment, consult the L-cysteine technical and quality guide.

Request Ingredient Specs & Quote

Share your target specification, application, quantity and document needs. We will help confirm suitable options, COA/TDS/SDS support and bulk supply details.

Related Ingredients for Formulation

Explore related ingredients for formula comparison, complementary applications and alternative sourcing options across food, beverage, supplement and wellness projects.